Ironwood Pharmaceuticals Inc
IRWDFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Ironwood Pharmaceuticals Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 17, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| IFP Advisors, Inc | 2026-03-31 | 4,033 | $14.2K | SEC filing |
| CM Management, LLC | 2026-03-31 | 350,000 | $1.23M | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 1,353 | $4.75K | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 484,036 | $1.7M | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 654,445 | Not shown | SEC filing |
| Root Financial Partners, LLC | 2026-03-31 | 133 | $467 | SEC filing |
| UBS Group AG | 2026-03-31 | 933,225 | $3.28M | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 32,746 | $115K | SEC filing |
| Engineers Gate Manager LP | 2026-03-31 | 79,852 | $280K | SEC filing |
| OVERSEA-CHINESE BANKING Corp Ltd | 2026-03-31 | 21,465 | $75.3K | SEC filing |
| Rafferty Asset Management, LLC | 2026-03-31 | 216,623 | $760K | SEC filing |
| VICTORY CAPITAL MANAGEMENT INC | 2026-03-31 | 713,187 | $2.5M | SEC filing |
| Amundi | 2026-03-31 | 404,237 | $1.42M | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 44,115 | $155K | SEC filing |
| Chicago Partners Investment Group LLC | 2026-03-31 | 18,483 | $77.3K | SEC filing |
| Ameritas Investment Partners, Inc. | 2026-03-31 | 13,773 | $48.3K | SEC filing |
| IAG Wealth Partners, LLC | 2026-03-31 | 1,000 | $3.51K | SEC filing |
| CAPTRUST FINANCIAL ADVISORS | 2026-03-31 | 74,930 | $263K | SEC filing |
| NorthCrest Asset Manangement, LLC | 2026-03-31 | 17,399 | $61.6K | SEC filing |
- Each value is checked against Ironwood Pharmaceuticals Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Ironwood Pharmaceuticals Inc's share price.
- 1 row left out: the value per share it reports is far from Ironwood Pharmaceuticals Inc's share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Ironwood Pharmaceuticals Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-17 · DENNER ALEXANDER J: Larger than all 111 other insider sales of Class A Common Stock on file. SEC filing
- 2026-02-24 · MCCOURT Thomas A: Larger than 106 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2026-02-23 · MCCOURT Thomas A: Larger than 105 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2025-02-10 · MCCOURT Thomas A: Larger than 108 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2024-06-06 · Moukheibir Catherine: Larger than 100 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2024-05-20 · MCCOURT Thomas A: Larger than 103 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2024-02-12 · MCCOURT Thomas A: Larger than 109 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2024-02-12 · John Minardo: Larger than 102 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2023-03-27 · MCCOURT Thomas A: Larger than 101 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2023-01-05 · MCCOURT Thomas A: Larger than 107 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2022-08-11 · Currie Mark G: Larger than 104 of the 111 other insider sales of Class A Common Stock on file. SEC filing
- 2022-06-07 · Currie Mark G: Larger than 110 of the 111 other insider sales of Class A Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-16 | McHugh Julie · Director | Class A Common Stock | S — Open market or private sale | −21,571 | 3.73 | SEC filing |
| 2026-03-17 | DENNER ALEXANDER J · Director | Class A Common Stock | S — Open market or private sale | −6,725,000 | 3.05 | SEC filing |
| 2026-03-17 | DENNER ALEXANDER J · Director | Class A Common Stock | S — Open market or private sale | −5,800 | 3.31 | SEC filing |
| 2026-02-24 | Shetzline Michael · SVP, CMO, Head-Res&Drug | Common Stock | S — Open market or private sale | +17,012 | 3.66 | SEC filing |
| 2026-02-24 | John Minardo · Chief Legal Officer | Class A Common Stock | S — Open market or private sale | −19,053 | 3.66 | SEC filing |
| 2026-02-24 | Martini Gregory S. · Chief Financial Officer | Class A Common Stock | S — Open market or private sale | −11,457 | 3.66 | SEC filing |
| 2026-02-24 | Silver Ronald · Principal Accounting Officer | Class A Common Stock | S — Open market or private sale | −12,621 | 3.66 | SEC filing |
| 2026-02-24 | Gaskins Tammi L · Chief Commercial Officer | Class A Common Stock | S — Open market or private sale | −11,239 | 3.66 | SEC filing |
Showing 8 of 13 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-16 | Moukheibir Catherine · Director | Class A Common Stock | A — Grant, award, or other acquisition | +63,481 | SEC filing |
| 2026-06-16 | Kessler Marla L · Director | Class A Common Stock | A — Grant, award, or other acquisition | +63,481 | SEC filing |
| 2026-06-16 | Currie Mark G · Director | Class A Common Stock | A — Grant, award, or other acquisition | +63,481 | SEC filing |
| 2026-06-16 | Shepard Jay · Director | Class A Common Stock | A — Grant, award, or other acquisition | +63,481 | SEC filing |
| 2026-06-16 | McHugh Julie · Director | Class A Common Stock | A — Grant, award, or other acquisition | +63,481 | SEC filing |
| 2026-06-16 | DENNER ALEXANDER J · Director | Class A Common Stock | A — Grant, award, or other acquisition | +63,481 | SEC filing |
| 2026-06-16 | Duane Jon R · Director | Class A Common Stock | A — Grant, award, or other acquisition | +63,481 | SEC filing |
| 2026-06-15 | DENNER ALEXANDER J · Director | Class A Common Stock | A — Grant, award, or other acquisition | +4,065 | SEC filing |
Showing 8 of 23 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.